Subscribe To
Osmotica pharmaceuticals announces pricing of $35 million underwritten public offering
BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica pharmaceuticals plc (Nasdaq: OSMT) (“Os...
October 7, 2021, 12:31 am
Osmotica pharmaceuticals announces pricing of $35 million underwritten public offering
BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica pharmaceuticals plc (Nasdaq: OSMT) (“Os...
October 7, 2021, 12:31 am
Xene stock: why it increased today
The stock price of Xenon pharmaceuticals Inc (NASDAQ: XENE) increased by over 6% today. This is why it ...
October 6, 2021, 10:26 pm
Xene stock: why it increased today
The stock price of Xenon pharmaceuticals Inc (NASDAQ: XENE) increased by over 6% today. This is why it ...
October 6, 2021, 10:26 pm
Xene stock: why it increased today
The stock price of Xenon pharmaceuticals Inc (NASDAQ: XENE) increased by over 6% today. This is why it ...
October 6, 2021, 10:26 pm
Aquestive therapeutics reaches agreement to extend principal payments due under credit facility to march 30, 2023 and receives bridge waiver of principal debt payment in advance of concluding formal a
WARREN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical<...
October 6, 2021, 5:59 pm
Aquestive therapeutics reaches agreement to extend principal payments due under credit facility to march 30, 2023 and receives bridge waiver of principal debt payment in advance of concluding formal a
WARREN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical<...
October 6, 2021, 5:59 pm
Aquestive therapeutics reaches agreement to extend principal payments due under credit facility to march 30, 2023 and receives bridge waiver of principal debt payment in advance of concluding formal a
WARREN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical<...
October 6, 2021, 5:59 pm
Aquestive therapeutics reaches agreement to extend principal payments due under credit facility to march 30, 2023 and receives bridge waiver of principal debt payment in advance of concluding formal a
WARREN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical<...
October 6, 2021, 5:59 pm
Aquestive therapeutics reaches agreement to extend principal payments due under credit facility to march 30, 2023 and receives bridge waiver of principal debt payment in advance of concluding formal a
WARREN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical<...
October 6, 2021, 5:59 pm
Aquestive therapeutics reaches agreement to extend principal payments due under credit facility to march 30, 2023 and receives bridge waiver of principal debt payment in advance of concluding formal a
WARREN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical<...
October 6, 2021, 5:59 pm
Rosen, a leading law firm, encourages spectrum pharmaceuticals, inc. investors with losses to secure counsel before important november 1 deadline in securities class action - sppi
NEW YORK, Oct. 6, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum ...
October 6, 2021, 5:06 pm
Rosen, a leading law firm, encourages spectrum pharmaceuticals, inc. investors with losses to secure counsel before important november 1 deadline in securities class action - sppi
NEW YORK, Oct. 6, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum ...
October 6, 2021, 5:06 pm
Rosen, a leading law firm, encourages spectrum pharmaceuticals, inc. investors with losses to secure counsel before important november 1 deadline in securities class action - sppi
NEW YORK, Oct. 6, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum ...
October 6, 2021, 5:06 pm
Osmotica pharmaceuticals plc announces proposed underwritten public offering
BRIDGEWATER, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Osmotica pharmaceuticals plc (Nasdaq: OSMT) (“Os...
October 6, 2021, 4:26 pm
Osmotica pharmaceuticals plc announces proposed underwritten public offering
BRIDGEWATER, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Osmotica pharmaceuticals plc (Nasdaq: OSMT) (“Os...
October 6, 2021, 4:26 pm
Osmotica pharmaceuticals plc announces proposed underwritten public offering
BRIDGEWATER, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Osmotica pharmaceuticals plc (Nasdaq: OSMT) (“Os...
October 6, 2021, 4:26 pm
Why takeda pharmaceutical stock is down more than 10% today
The prescription drugmaker is halting a trial before a scheduled stopping point, suggesting it's too dangerous to expect an approval....
October 6, 2021, 3:54 pm
Why takeda pharmaceutical stock is down more than 10% today
The prescription drugmaker is halting a trial before a scheduled stopping point, suggesting it's too dangerous to expect an approval....
October 6, 2021, 3:54 pm
Why takeda pharmaceutical stock is down more than 10% today
The prescription drugmaker is halting a trial before a scheduled stopping point, suggesting it's too dangerous to expect an approval....
October 6, 2021, 3:54 pm